E
Ultragenyx Pharmaceutical Inc. RARE
$29.78 $0.260.88% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Net Income -114.95M -151.08M -133.39M -133.52M -131.60M
Total Depreciation and Amortization 8.62M 8.99M 9.08M 8.76M 8.86M
Total Amortization of Deferred Charges -- -- -- -- --
Total Other Non-Cash Items 19.87M 32.25M 22.05M 26.94M 29.42M
Change in Net Operating Assets -21.81M -56.63M 22.75M 30.83M 16.36M
Cash from Operations -108.27M -166.48M -79.50M -67.00M -76.96M
Capital Expenditure -2.46M -1.32M -654.00K -1.62M -2.01M
Sale of Property, Plant, and Equipment -- -- -- -- --
Cash Acquisitions -- -- -- -- --
Divestitures -- -- -- -- --
Other Investing Activities 73.64M 121.21M 103.39M -273.89M 62.57M
Cash from Investing 71.18M 119.89M 102.74M -275.50M 60.56M
Total Debt Issued -- -- -- -- --
Total Debt Repaid -- -- -- -- --
Issuance of Common Stock 83.65M 157.00K 3.19M 4.17M 384.88M
Repurchase of Common Stock -- -- -- -- --
Issuance of Preferred Stock -- -- -- -- --
Repurchase of Preferred Stock -- -- -- -- --
Total Dividends Paid -- -- -- -- --
Other Financing Activities -- -- 0.00 7.00M 58.00K
Cash from Financing 83.65M 157.00K 3.19M 11.17M 384.94M
Foreign Exchange rate Adjustments 2.91M 1.45M -2.47M 1.28M -648.00K
Miscellaneous Cash Flow Adjustments -- -- -- -- --
Net Change in Cash 49.47M -44.98M 23.95M -330.05M 367.89M